Comprehensive Chronic Kidney Disease Evaluation & Progression Management
Clinical Practice & Guidelines • Dr. Fayaz Ahmad Wani (MD SKIMS, DM Nephrology Osmania Gold Medalist)
1. Understanding Chronic Kidney Disease (CKD)
Chronic Kidney Disease (CKD) describes the gradual, progressive loss of renal function over months to years. In its early stages (Stages 1 through 3), CKD is frequently asymptomatic — earning it the clinical designation of a "silent condition." Left unmanaged, gradual nephron loss can advance to end-stage renal disease (ESRD), requiring renal replacement therapy (dialysis or kidney transplantation).
Under the clinical leadership of Dr. Fayaz Ahmad Wani (Senior Consultant Nephrologist & Kidney Transplant Specialist, DM Nephrology Gold Medalist), our clinic prioritizes early detection, precision staging via estimated Glomerular Filtration Rate (eGFR) and Urine Albumin-to-Creatinine Ratio (UACR), and targeted pharmacotherapy to arrest or significantly retard disease progression.
2. Clinical Staging of Kidney Disease by eGFR
Renal function is formally classified into five stages based on the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, correlating eGFR (mL/min/1.73m²) with structural renal markers:
| CKD Stage | eGFR Range | Clinical Description | Primary Clinical Goals |
|---|---|---|---|
| Stage 1 | ≥ 90 | Normal or elevated GFR with persistent kidney damage (proteinuria) | Diagnosis, treating underlying cause, CVD risk reduction |
| Stage 2 | 60 – 89 | Mild reduction in GFR with persistent kidney markers | Estimating progression rate, blood pressure & glycemic control |
| Stage 3a / 3b | 30 – 59 | Moderate to severe reduction in kidney filtration capacity | Evaluating & managing complications (anemia, CKD-MBD, electrolytes) |
| Stage 4 | 15 – 29 | Severe reduction in filtration; impending renal failure | Renal replacement therapy education, AV fistula vascular planning |
| Stage 5 | < 15 | Kidney Failure (End-Stage Renal Disease / Uremia) | Pre-emptive kidney transplantation, hemodialysis, or peritoneal dialysis |
3. Evidence-Based Strategies to Slow Progression
Contemporary nephrology provides proven pharmacological and lifestyle interventions that can preserve remaining nephron mass for years:
- Hemodynamic Renoprotection (RAS Blockade): Optimizing Angiotensin-Converting Enzyme (ACE) inhibitors or Angiotensin Receptor Blockers (ARBs) to diminish intraglomerular capillary hypertension and lower albumin leakage.
- SGLT2 Inhibitor Therapy: Prescribing modern SGLT2 inhibitors (Empagliflozin, Dapagliflozin) validated in landmark clinical trials to decelerate eGFR decline and provide substantial cardioprotection.
- Non-Steroidal Mineralocorticoid Receptor Antagonists: Targeted finerenone therapy to attenuate renal inflammation and progressive interstitial fibrosis.
- Strict Blood Pressure Targets: Maintaining individualized arterial blood pressure (typically <120–130/80 mmHg in proteinuric patients) verified through home monitoring.
- Precision Renal Nutrition: Monitored dietary protein intake (0.6–0.8 g/kg/day in non-dialysis CKD), sodium restriction (<2,000 mg/day), and personalized potassium and phosphorus adjustments based on periodic serum biochemistry.
- Nephrotoxic Drug Avoidance: Strict elimination of non-steroidal anti-inflammatory drugs (NSAIDs / OTC pain relievers) and unnecessary iodinated radiocontrast agents.
4. Management of Secondary CKD Complications
As renal mass diminishes, endocrine and metabolic functions are impaired. Dr. Fayaz Ahmad Wani delivers proactive management across all systemic manifestations:
- Renal Anemia: Treatment with erythropoiesis-stimulating agents (ESAs) and intravenous iron formulations to preserve cardiovascular vitality and cognitive focus.
- Mineral & Bone Disorder (CKD-MBD): Managing calcium, phosphorus, alkaline phosphatase, and intact parathyroid hormone (iPTH) through non-calcium phosphate binders and active vitamin D analogs.
- Metabolic Acidosis & Hyperkalemia: Judicious sodium bicarbonate supplementation and modern potassium binders to maintain physiological acid-base and electrolyte homeostasis.
- Fluid Overload & Edema: Loop diuretic optimization to control peripheral edema and pulmonary congestion without compromising renal perfusion.
Consult with Dr. Fayaz Ahmad Wani
Senior Consultant Nephrologist & Kidney Transplant Specialist • OPD at Fortis Escorts Hospital (10am–4pm) & Primus Medicare (5:30pm–7pm)